中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
2-氯-3-甲基喹喔啉 | 2-chloro-3-methylquinoxaline | 32601-86-8 | C9H7ClN2 | 178.621 |
3-甲基-3-喹诺醇 | 3-Methyl-2-oxo-1,2-dihydroquinoxaline | 14003-34-0 | C9H8N2O | 160.175 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
3-乙基-2(1H)-喹喔啉硫酮 | 3-ethyl-1H-quinoxaline-2-thione | 658686-30-7 | C10H10N2S | 190.269 |
2(1H)-喹喔啉硫酮,3-丙基- | 3-propyl-1H-quinoxaline-2-thione | 100061-41-4 | C11H12N2S | 204.296 |
2(1H)-喹喔啉硫酮,3-戊基- | 2(1H)-Quinoxalinethione, 3-pentyl- | 100616-83-9 | C13H16N2S | 232.349 |
—— | 3-(2-hydroxy-2-methylhexyl)-1H-quinoxaline-2-thione | —— | C15H20N2OS | 276.403 |
A new series of 3-methylquinoxaline-based derivatives having the same pharmacophoric features of VEGFR-2 inhibitors have been synthesized and evaluated for their antiproliferative activities against MCF-7 and HepG-2 cells.